Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2010
09/29/2010CN101845057A Substituted phenol for methylal phosphate anesthetic and sedative drugs and preparation method thereof
09/29/2010CN101845034A Preparation and application method of scutellarin
09/29/2010CN101845028A Heterodimer type compound using indenone and thiophenylamine as parent nucleus
09/29/2010CN101845018A Non-catechol aporphine compound as well as pharmaceutic composition and application thereof
09/29/2010CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/29/2010CN101843887A Traditional Chinese medicine for drug addiction treatment
09/29/2010CN101843801A Bone permeable blood-activating and pain-relieving tincture
09/29/2010CN101843680A Application of composite containing polygonum orientale in preventing and treating climacteric diseases and delaying aging
09/29/2010CN101843652A Moleplant seed composite essential oil
09/29/2010CN101843638A Method for extracting horny substance liquid by using animal horns or hooves and equipment thereof
09/29/2010CN101843630A Composite containing iridoid compound and application thereof
09/29/2010CN101843629A New application of icariin and epimedium flavone containing icariin
09/29/2010CN101843618A Application of berberine and derivatives thereof in preparation of indole amine 2, 3-dioxygenase inhibitor
09/29/2010CN101843610A Use of arachidonic acid for normalization of infradian rhythm
09/29/2010CN101843601A Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
09/29/2010CN101843597A Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
09/29/2010CN101843596A Methadone hydrochloride dispersible tablet and preparation method thereof
09/29/2010CN101843590A Extended release venlafaxine formulation
09/29/2010CN101843587A Method for preparing ornithine aspartate powder injection for injection
09/29/2010CN101843581A Multi-portion intra-oral dosage form with organoleptic properties
09/29/2010CN101843423A Chinese medicinal pillow
09/29/2010CN101843422A Chinese medicinal pillow
09/29/2010CN101843421A Medicinal pillow
09/29/2010CN101843420A Medicine pillow
09/29/2010CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition
09/29/2010CN101332211B Leech extract and preparation method and use thereof
09/29/2010CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease
09/29/2010CN101314591B Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent
09/29/2010CN101301293B Acidum folicum effervescent tablet and preparation thereof
09/29/2010CN101293039B Compound essential oil for refreshing oneself, and eliminating fatigue
09/29/2010CN101278926B Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
09/29/2010CN101264197B Medicine for treating sciatica
09/29/2010CN101249246B Proprietary Chinese medicine preparations for curing depression after cerebral infarction
09/29/2010CN101228137B Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
09/29/2010CN101072771B Cgrp receptor antagonists
09/29/2010CN101061106B Potentiators of glutamate receptors
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/29/2010CN101005830B Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
09/28/2010USRE41783 Pyrrolo[2,3-D]pyrimidine compounds
09/28/2010US7803830 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine
09/28/2010US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors
09/28/2010US7803810 Inhibitors
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents
09/28/2010US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease
09/28/2010US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response
09/28/2010US7803739 Substrates and assays for β-secretase
09/28/2010US7803615 Death domain containing receptor 5
09/28/2010US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/28/2010CA2553160C 2-heteroaryl-substituted benzimidazole derivative
09/28/2010CA2527587C Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists
09/28/2010CA2504614C Process for the preparation of imidazolyl compounds
09/28/2010CA2481707C Benzopyran derivatives substituted with secondary amines having tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
09/28/2010CA2478515C Pharmaceutical preparation containing oxycodone and naloxone
09/28/2010CA2448038C Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
09/28/2010CA2415475C Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/28/2010CA2382247C Azaindoles having serotonin receptor affinity
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/28/2010CA2238050C Inhibitors of cyclophilin rotamase activity
09/27/2010CA2697867A1 Multi-portion intra-oral dosage form with organoleptic properties
09/23/2010WO2010108067A1 Alpha-(n-benzenesulfonamido)cycloalkyl derivatives
09/23/2010WO2010108052A2 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010WO2010108008A2 Bsc cell differentiation and use in therapy
09/23/2010WO2010107997A1 Thiophenyl sulfonamides for the treatment of alzheimer's disease
09/23/2010WO2010107984A1 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production a novel alpha-(n-sulfonamido) acetamide compound incorporating deuterium as inhibitor of beta amyloid peptide production
09/23/2010WO2010107866A2 Catecholamine derivatives for obesity and neurological disorders
09/23/2010WO2010107435A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010107150A1 Pharmaceutical composition for the prevention and treatment of ischemic brain diseases
09/23/2010WO2010107115A1 Glycine transporter inhibitor
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106495A1 Sceletium extract and uses thereof
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010106333A1 Compounds
09/23/2010WO2010106270A1 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010WO2010106249A1 Benzothiadiazepine derivatives used as ampa and nmda receptor modulators
09/23/2010WO2010106145A1 Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments
09/23/2010WO2010106106A1 2, 5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
09/23/2010WO2010105960A1 Substituted pyridine derivatives and their medical use
09/23/2010WO2010105930A1 Carbamate derivatives in particular for the treatment of neurological disorders
09/23/2010WO2010105685A1 Peptides for inhibiting igf-1
09/23/2010WO2010081622A3 Food supplement for the treatment of neuropathies
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010WO2010072774A3 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal
09/23/2010WO2010059242A3 Neurodegenerative disease diagnostic compositions and methods of use
09/23/2010WO2010058926A3 Pharmaceutical composition containing ginger extract or shogaol
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010US20100242127 Methods to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression
09/23/2010US20100240897 Spirocyclic Cyclohexane Compounds
09/23/2010US20100240768 Novel nutraceuticalcompositions containing thymol and/or p-cymene or plant extracts for cognition
09/23/2010US20100240764 Use of S-Clenbuterol
09/23/2010US20100240763 Method to Determine and Biomarker for Treatment Efficacy With Ssri, Snri, and Sari Antidepressants
09/23/2010US20100240748 Tetrahydronaphthalen-2-ol derivatives
09/23/2010US20100240746 Stereoisomers of tricyclodecan-9-yl-xanthogenate
09/23/2010US20100240744 Methods for the treatment of dementia based on apo e genotype
09/23/2010US20100240743 Cannabinoid receptor modulator
1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 1833